Imagine a treasure trove of medical secrets, locked away in decades-old tissue samples, potentially holding the key to understanding why diseases are changing and becoming more aggressive. But what if we told you that accessing this information, long considered lost to time, is now becoming a reality?
For years, research institutions have been sitting on a goldmine of genetic data, tucked away in preserved medical tissues. These samples could revolutionize our understanding of countless diseases. The problem? DNA degrades. Traditional methods struggle to analyze DNA that's been sitting around for more than 20 years. Think of it like trying to read a faded photograph – the details become blurred and indistinct.
Modern technologies have given us incredible tools to study disease, but almost all of that has been focused on new genetic samples. The ability to rewind the clock and study genetic data from the past has been severely limited. This has created a major roadblock in understanding old diseases, and critically, why diseases evolve and change over time.
But here's where it gets controversial... Some might argue that focusing on modern samples is more efficient, given the resources required to analyze degraded DNA. Is it truly worth investing in these older samples, or should we prioritize the readily available, high-quality data from contemporary cases?
Now, researchers at the University of Chicago have developed a groundbreaking approach. By adapting techniques originally designed to study ancient DNA from archaeological digs (think woolly mammoths and ancient humans!), they've managed to successfully recover genetic information from medical samples that are nearly a century old. It's like finding a way to sharpen that faded photograph and reveal incredible details.
This exciting breakthrough is set to be presented at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo in Boston, from November 11th to 15th. Get ready for some serious buzz!
To demonstrate the power of their technique, the team focused on colorectal cancer. They analyzed tissue samples collected between 1932 and 2023, a period that marks a significant shift in the disease's prevalence. And this is the part most people miss... Colorectal cancer is becoming alarmingly more common in younger adults, with no clear explanation as to why. Today, a 35-year-old is twice as likely to develop this cancer compared to someone the same age in 1985. That's a terrifying statistic, and understanding the genetic changes over time could be crucial in reversing this trend.
The process is intricate, but here's the gist: First, they carefully extract tumor tissue from formalin-fixed paraffin-embedded (FFPE) specimens. These specimens, while great for preservation, can actually damage DNA. So, the researchers had to optimize the removal of paraffin wax and those pesky chemical preservatives to maximize the amount of usable DNA. Think of it as carefully unwrapping a fragile artifact.
Next, they use specialized methods to prepare the fragmented DNA for sequencing. Because the DNA is often broken into small pieces, they created a custom pipeline using digital tools typically used for ancient DNA analysis. This allows them to piece together the fragments and match them to the human genome. It's like reconstructing a shattered vase, piece by piece.
After ensuring the DNA is of sufficient quality, they perform whole-genome sequencing and use a targeted gene-enrichment panel (OncoPlus) to identify genetic mutations that fuel tumor growth. Critically, they modified these protocols to retain even the tiniest DNA fragments, which are usually discarded. Every little piece of information counts!
Finally, and perhaps surprisingly, they analyze the non-human DNA – the bacteria – found within the tissue samples. Dr. Alexander Guzzetta, M.D., Ph.D., who led the project with ancient DNA expert Dr. Maanasa Raghavan, explains, "When we analyzed bacterial DNA from colon cancer tissues, we not only detected normal gut microbes but also bacterial species which are specifically associated with colon cancer." The team is now refining their methods to better understand these bacteria and how their presence may have changed over time. This raises a fascinating possibility: could changes in the gut microbiome be contributing to the rise in colorectal cancer among young adults?
Guzzetta's team is currently focused on colorectal cancer, but he envisions a much broader application of this technique. "There is massive potential here for other groups to use these approaches to unravel the root causes underlying the shifting landscape of modern diseases," he says. "This approach could unlock the ability to study how diseases evolve over decades and shed light on how their biology has changed through time." Imagine using this technology to track the evolution of viruses, understand the genetic basis of Alzheimer's disease, or even predict future disease outbreaks.
This work, spearheaded by Dr. Alexander Guzzetta at the University of Chicago, will be presented on November 13th at 2:45 p.m. Eastern time at the Thomas M. Menino Convention and Exhibition Center in Boston. Dr. Guzzetta will also present his work in a poster session (poster number TT008) and will be available to discuss his findings with reporters. This is definitely a presentation you won't want to miss if you're interested in the future of medical research.
So, what do you think? Is this new approach a game-changer for understanding disease evolution? Are there ethical considerations we should be mindful of when working with historical tissue samples? Share your thoughts in the comments below!
